Who
Chandra Vargeese
Officer
Company insider
Files Form 4 as: Chief Technology Officer, Wave Life Sciences.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $923K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jun 2016
- Last trade
- 9 Feb 2026
- Last filed
- 11 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $43K3,228 at $13.45 | filing |
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $43K3,228 at $13.45 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —45,625 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,750 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,750 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —45,625 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,422 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —75,332 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $228K91,754 at $2.48 | filing |
| 4 Feb 2025filed 6 Feb 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —224,000 at $0.00 | filing |
| 4 Feb 2025filed 6 Feb 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 23 Jan 2025filed 24 Jan 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —46,000 at $0.00 | filing |
| 23 Jan 2025filed 24 Jan 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $114K46,000 at $2.48 | filing |
| 22 Jul 2024filed 24 Jul 2024 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —68,210 at $0.00 | filing |
| 22 Jul 2024filed 24 Jul 2024 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $169K68,210 at $2.48 | filing |
| 5 Feb 2024filed 7 Feb 2024 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —361,700 at $0.00 | filing |
| 17 Feb 2023filed 17 Feb 2023 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —295,400 at $0.00 | filing |
| 16 Feb 2023filed 17 Feb 2023 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $41K10,249 at $4.03 | filing |
| 25 Jul 2022filed 27 Jul 2022 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 5 May 2022filed 6 May 2022 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $29K16,714 at $1.72 | filing |
News
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026WVE · manilatimes.net · 20 Oct 2026Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026WVE · manilatimes.net · 19 Oct 2026WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonWVE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Chandra Vargeese; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.